Nutraceutix#s L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism

Food and Healthcare Press Releases Wednesday July 29, 2015 12:00
REDMOND, Washington--29 Jul--PRNewswire/InfoQuest

A German Diabetes Center clinical study found that daily ingestion of Nutraceutix's L. reuteri probiotic enriches human gut microbiota and modifies gut production of protein factors that increase insulin secretion.   The study involved daily administration of Nutraceutix's L. reuteri strain (ATCC strain SD-5865) in tablets using the patented BIO-tract(R) delivery technology that protects live probiotics from damage by stomach acid on their way to the intestinal tract.

Logo -

The randomized, double-blind, placebo-controlled study compared secretion of insulin, C-peptide, and proglucagon-derived peptides and pancreatic beta-cell function in glucose-stimulated non-diabetic participants to measure incretin effect.   Participants took L. reuteri tablets or placebo tablets daily over a four-week period.   People taking the L. reuteri had increased glucose-stimulated insulin secretion by 49%, C-peptide secretion by 55%, GLP-1 release by 76%, GLP-2 release by 43%, and altered beta-cell function relative to people taking the placebo.   In a related presentation before the American Diabetes Association, the study's primary researcher concluded, "probiotic treatment may improve incretin-mediated beta-cell function, which could be beneficial for the treatment of glucose intolerance or overt type 2 diabetes."

Detailed gut microbiota composition analysis of the study participants was done before and after the study.   After the study, all those taking L. reuteri BIO-tract tablets had detectable L. reuteri in their stool samples, while those tested from the placebo group did not.   No participants reported adverse effects.

The study article was published online along with supplementary data, at the American Diabetes Association(R) (ADA) Diabetes Care(R) website in June 2015, doi: 10.2337/dc14-2690.   The referenced presentation was made at the 72nd Scientific Sessions of the ADA, Philadelphia, PA, in June 2012.   A webcast of the presentation can be found at the website.

Nutraceutix is a Registered GMP contract manufacturer of probiotics in bulk powder, and in standard and advanced capsule and tablet forms.   Nutraceutix's BIO-tract technology is protected by U.S. Patent Nos. 8,540,980 and 8,007,777, and over 30 international patents.

Disclaimer:   BIO-tract is a registered trademark of Nutraceutix.   Nutraceutix is not affiliated with the American Diabetes Association.   The American Diabetes Association(R) and Diabetes Care(R) are trademarks owned by their respective holders.   Use of them does not imply affiliation or endorsement by them.

Latest Press Release

Future Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare

Royal Philips (NYSE: PHG) (AEX: PHIA), a global leader in health technology, today released a new Future Health Index (FHI) report " Moving data to the heart of health systems: Increasing vital technology adoption to make value-based healthcare a reality...

PULSUS Group collaborates with Anbu Kochi to Contribute towards Kerala Flood Victims

In a humanitarian effort, PULSUS Group - in collaboration with Anbu Kochi - is responding to the calamity of the recent, unprecedented floods in the Indian state of Kerala by providing contributions to aid relief and rehabilitation measures. PULSUS Group...

Menarini Ricerche Announces New Positive Results in Acute Myeloid Leukemia Cell Lines for MEN1112/OBT357 at the 60th Annual SIC Meeting

Menarini Ricerche will present tomorrow, September 20th, at the 60th Annual Meeting of the Italian Cancer Society (SIC), new preclinical data showing that pre-treatment with 5-Azacytidine and Decitabine enhances the Antibody-dependent cellular...

Experts Call for Improved Identification of #High Burden# Rosacea Patients in Everyday Practice

- Additional analysis of global survey data reveals quality of life is impacted by several factors extending beyond severity of rosacea alone Additional analysis of a global survey conducted and presented earlier this year, as an expert-authored report...

BookDoc collaborates with Chow Tai Fook: Get more rewards by staying active together with Chow Tai Fook

Chow Tai Fook is collaborating with BookDoc, the largest integrated healthcare app in Southeast Asia by healthcare network in giving more rewards to BookDoc users for maintaining an active healthy lifestyle. Users can now enjoy discounts and redeem...

Related Topics